Conference Coverage

Interrupting oral anticoagulation in AF carries high thromboembolic cost

Publish date: November 1, 2016

 

AT THE ESC CONGRESS 2016

Pages

Recommended Reading

Solid INRs on warfarin don’t predict future stability
MDedge Family Medicine
VIDEO: NOACs cut intracranial bleeds in real-world atrial fib patients
MDedge Family Medicine
VIDEO: ICDs cut mortality in younger, healthier heart failure patients
MDedge Family Medicine
Commentary: INR instability in the NOAC era
MDedge Family Medicine
Trials offer lessons despite negative primary endpoints
MDedge Family Medicine
Rivaroxaban linked to more bleeding compared with dabigatran in elderly patients with nonvalvular AF
MDedge Family Medicine
FDA reaffirms rivaroxaban’s atrial fib efficacy in ROCKET AF
MDedge Family Medicine
Beta-blockers curb death risk in patients with primary prevention ICD
MDedge Family Medicine
Joint European atrial fibrillation guidelines break new ground
MDedge Family Medicine
Adaptive servo ventilation cuts atrial fib burden
MDedge Family Medicine